Back to Search
Start Over
Improved survival in patients with refractory cytopenias (low risk myelodysplastic syndrome - MDS) treated with allogeneic T-cell depleted hematopoietic stem cell transplants (allo TCD-HSCTs)
- Authors :
- Jhaveri, A.
Papadopoulos, E. B.
Jakubowski, A. A.
Boulad, F.
Nancy Kernan
Small, T. N.
Perales, M. A.
Maloy, M.
Montes-Gaisan, C.
O Reilly, R. J.
Young, J. W.
Castro-Malaspina, H. R.
- Source :
- Memorial Sloan Kettering Cancer Center
Details
- Database :
- OpenAIRE
- Journal :
- Memorial Sloan Kettering Cancer Center
- Accession number :
- edsair.dedup.wf.001..ab30094b33713046f23d18dc8dc89775